On 17 June 2021, the US Food and Drug Administration (FDA) announced approval of a new nasal antihistamine (Astepro Allergy and Children’s Astepro Allergy) for…
John EvansJune 21, 2021
Latest News
Innovating at Unprecedented Pace COVID-19 prompted dramatic changes in the way we conduct research. In the months since the pandemic began, we have completed literally…
John EvansFebruary 8, 2021
We are pleased to announce Brandon Henrie has been promoted to Vice President – Finance and Strategy. In this new role, Brandon focuses on company…
John EvansFebruary 8, 2021
On 28 Feb. 2020, the US Food and Drug Administration (FDA) approved a novel fixed-dose combination oral pain reliever (Advil Dual Action with Acetaminophen) for…
John EvansMarch 5, 2020
An analysis of the use of time sampling strategies (subject reports of medication dosing behavior in the period preceding a study contact) compared to daily…
John EvansSeptember 15, 2019
On November 7, 2018, FDA’s CDER approved a new version of Primatene Mist as the only OTC metered-dose inhaler. Primatene is for the temporary relief…
John EvansJanuary 28, 2019
Key staff from PEGUS (Dr. Russ Bradford, Sarah Farnsworth, Kimberly Anderson and Clark Richardson) participated in an innovative session at the 2018 Regulatory, Scientific and…
John EvansJune 27, 2018
Learn more about PEGUS
Our Pharmaceutical Research Services
Learn More
Join our Pharmacy Network.
Are you a registered pharmacist interested in joining our network?
Learn More
